AI 지원 방사선 치료 계획 소프트웨어 시장 규모, 점유율, 동향 분석 보고서 : 도입 형태별, 구성요소별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

AI-assisted Radiation Therapy Planning Software Market Summary

The global AI-assisted radiation therapy planning software market size was valued at USD 659.6 million in 2025 and is projected to grow from USD 743.5 million in 2026 to USD 1,815.3 million by 2033, at a CAGR of 13.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.4% in 2025. Growth is driven by the rising prevalence of cancer, the increased demand for precise, personalized radiation therapy, and the broader adoption of artificial intelligence in radiation oncology. AI-assisted software automates treatment planning, contouring, dose optimization, and quality assurance, which improves workflow efficiency and treatment consistency. The expanded use of adaptive radiotherapy, combined with the need to reduce planning time and address anatomical changes during treatment, is also expected to accelerate market growth.

Global AI-assisted Radiation Therapy Planning Software Market Report Segmentation

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of industry trends in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global AI-assisted radiation therapy planning software market report on the basis of deployment mode, component, end use, and region:

• Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
• On-Premise
• Cloud-Based
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Software
  • AI-based treatment planning software
  • Adaptive radiotherapy (ART) software
  • Auto-contouring/auto-segmentation software
  • Dose optimization software
  • Image registration & fusion software
  • Quality assurance (QA) software
• Services
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Dedicated cancer/oncology treatment centers
• Ambulatory surgical/radiotherapy centers
• Others (diagnostic imaging centers, academic & research institutes)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Deployment Mode outlook
  • 2.2.2. Component
  • 2.2.3. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Global AI-assisted Radiation Therapy Planning Software Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Global AI-assisted Radiation Therapy Planning Software: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's five forces analysis
  • 3.3.2. PESTLE Analysis
• 3.4. Case Studies

Chapter 4. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Deployment Mode, 2021-2033 (Revenue in USD Million)

• 4.1. Definition and Scope
• 4.2. Deployment Mode Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global AI-assisted Radiation Therapy Planning Software Market, by Deployment Mode, 2021 to 2033
  • 4.4.1. On-Premise
    • 4.4.1.1. On-premise market estimates and forecasts 2021 to 2033, (USD Million)
  • 4.4.2. Cloud-Based
    • 4.4.2.1. Cloud-based market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 5. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Component, 2021-2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Component Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global AI-assisted Radiation Therapy Planning Software Market, by Component, 2021 to 2033
• 5.5. Software
  • 5.5.1. Software market estimates and forecasts 2021 To 2033, (USD Million)
  • 5.5.2. AI-Based Treatment Planning Software
    • 5.5.2.1. AI-based treatment planning software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.5.3. Adaptive Radiotherapy (ART) Software
    • 5.5.3.1. Adaptive radiotherapy (art) software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.5.4. Auto-Contouring/Auto-Segmentation Software
    • 5.5.4.1. Auto-contouring/auto- segmentation software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.5.5. Dose Optimization Software
    • 5.5.5.1. Dose optimization software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.5.6. Image Registration & Fusion Software
    • 5.5.6.1. Image registration & fusion software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.5.7. Quality Assurance (QA) Software
    • 5.5.7.1. Quality assurance (QA) software market estimates and forecasts 2021 to 2033, (USD Million)
• 5.6. Services
  • 5.6.1. Services market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 6. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By End Use, 2021-2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Global AI-assisted Radiation Therapy Planning Software Market, by End Use, 2021 to 2033
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 6.6. Dedicated Cancer/Oncology Treatment Centers
  • 6.6.1. Dedicated cancer/oncology treatment centers market estimates and forecasts, 2021 to 2033 (USD million)
• 6.7. Ambulatory Surgical/Radiotherapy Centers
  • 6.7.1. Ambulatory surgical/radiotherapy centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Others (diagnostic imaging centers, academic & research institutes)
  • 6.8.1. Others (diagnostic imaging centers, academic & research institutes) market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 7. AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. AI-assisted Radiation Therapy Planning Software Market Share by Region, 2025 & 2033:
• 7.5. North America
  • 7.5.1. North America AI-assisted radiation therapy planning software market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
• 7.6. Europe
  • 7.6.1. Europe AI-assisted Radiation Therapy Planning Software market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Commercial Strategies
• 8.4. Company Profiles
  • 8.4.1. Varian Medical Systems, Inc. (Siemens Healthineers)
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Elekta AB
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. RaySearch Laboratories
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Accuray Incorporated.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Brainlab SE
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. GE HealthCare Technologies Inc.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Koninklijke Philips N.V.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. MVision AI
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Mirada Medical Ltd.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. DOSIsoft SA
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Radformation, Inc.
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. TheraPanacea
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives